Cameron Durrant Insider Trading $KBIO HUMANIGEN, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cameron Durrant.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cameron Durrant. Cameron Durrant is Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and Chairman and CEO in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Chief Executive Officer in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in ANAVEX LIFE SCIENCES CORP. ($AVXL).
Cameron Durrant in HUMANIGEN, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cameron Durrant: Chief Executive Officer, Chairman and CEO
Holdings: 557,207 shares
Current Value: $1,610,328
Latest Transaction: Mar 15 2021
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cameron Durrant in HUMANIGEN, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXL, KBIO, IMNP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 16.07 | 652,640 | 10,487,925 | 652,640 | |
| Oct 07 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 12.14 | 82,622 | 1,003,031 | 82,622 | |
| May 21 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.86 | 250,000 | 215,000 | 250,000 | |
| Jan 29 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.40 | 318,103 | 127,241 | 318,103 | |
| Jun 05 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 1.25 | 8,000 | 10,000 | 557,207 | 549.2 K to 557.2 K (+1.46 %) |
| May 31 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Buy | J | 0.00 | 235,624 | 0 | 549,207 | 313.6 K to 549.2 K (+75.14 %) |
| Apr 25 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,359,771 | |
| Apr 25 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 313,583 | 238.6 K to 313.6 K (+31.44 %) |
| Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,434,771 | |
| Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 238,583 | 163.6 K to 238.6 K (+45.85 %) |
| Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,434,771 | |
| Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 238,583 | 163.6 K to 238.6 K (+45.85 %) |
| Jan 28 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.84 | 142,857 | 120,000 | 142,857 | |
| Jan 28 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.84 | 142,857 | 120,000 | 142,857 | |
| Dec 14 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.82 | 4,000 | 3,264 | 163,583 | 159.6 K to 163.6 K (+2.51 %) |
| Dec 14 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.82 | 2,000 | 1,644 | 159,583 | 157.6 K to 159.6 K (+1.27 %) |
| Dec 12 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.76 | 2,500 | 1,893 | 157,583 | 155.1 K to 157.6 K (+1.61 %) |
| Dec 12 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.75 | 2,500 | 1,875 | 155,083 | 152.6 K to 155.1 K (+1.64 %) |
| Dec 10 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.74 | 7,000 | 5,173 | 152,583 | 145.6 K to 152.6 K (+4.81 %) |
| Dec 10 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.73 | 10,000 | 7,320 | 145,583 | 135.6 K to 145.6 K (+7.38 %) |
| Mar 13 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.67 | 7,466,749 | 4,965,388 | 8,509,771 | |
| Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 3.38 | 1,043,022 | 3,525,414 | 1,043,022 | |
| Jul 05 2016 | KBIO | KALOBIOS PHARMACEU ... | Durrant Cameron | Chairman and CEO | Grant | A | 0.00 | 135,583 | 0 | 135,583 | 0 to 135.6 K |
Page: 1